Becton, Dickinson And Company Share Price (NYSE: BDX)

$192.88

▲

1.63

(0.85%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Becton, Dickinson And Company Stock chart to analyse performance

Becton, Dickinson And Company stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$191.66
Today's High:$192.97
$192.88
0.63%
Downside
Day's Volatility :0.68%
Upside
0.05%
52 Weeks Low:$163.33
52 Weeks High:$251.99
$192.88
15.32%
Downside
52 Weeks Volatility :35.18%
Upside
23.46%

Becton, Dickinson And Company Stock Returns

Period	Becton, Dickinson And Company	Sector (Health Care)	Index (Russel 2000)
3 Months	13.92%	3.6%	0.0%
6 Months	-15.53%	-7.7%	0.0%
1 Year	-20.32%	-12.6%	0.0%
3 Years	-23.68%	8.4%	-3.0%

Becton, Dickinson And Company Key Stats

Check Becton, Dickinson And Company key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$191.25
Open	$192.0
Today's High	$192.97
Today's Low	$191.66
Market Capitalization	$55.3B
Today's Volume	$1.3M
52 Week High	$251.985
52 Week Low	$163.33
Revenue TTM	$21.4B
EBITDA	$5.9B
Earnings Per Share (EPS)	$5.46
PE Ratio	35.34
Dividend Yield	2.13%
Profit Margin	7.41%
Quarterly Earnings Growth YOY	0.19%
Return On Equity TTM	6.18%

Stock Returns calculator for Becton, Dickinson And Company Stock including INR - Dollar returns

The Becton, Dickinson And Company stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Becton, Dickinson And Company investment value today

Current value as on today

₹84,927

Returns

₹15,073

(-15.07%)

Returns from Becton, Dickinson And Company Stock

₹20,357 (-20.36%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Becton, Dickinson And Company Stock

-13%

Period: Aug 1, 2025 to Aug 31, 2025. Change in 30 Days versus previous period

Search interest for Becton, Dickinson And Company Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Becton, Dickinson And Company Stock

Name	Shares Held	Change in Shares	% of Assets
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	448	0.00	0.42%
Motilal Oswal S&P 500 Index Fund Direct Growth	2317	-26.97	0.09%

Global Institutional Holdings in Becton, Dickinson And Company

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.27%
BlackRock Inc
8.33%
T. Rowe Price Investment Management,Inc.
5.64%
State Street Corp
4.88%
T. Rowe Price Associates, Inc.
3.10%
Arnhold & S. Bleichroeder Advisers, LLC
3.07%

Analyst Recommendation on Becton, Dickinson And Company Stock

Rating

Trend

Buy

70%Buy

30%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Becton, Dickinson And Company(by analysts ranked 0 to 5 stars)

Becton, Dickinson And Company Share Price Target

What analysts predicted

Upside of 7.84%

Target:

$208.00

Current:

$192.88

Becton, Dickinson And Company share price target is $208.00, a slight Upside of 7.84% compared to current price of $192.88 as per analysts' prediction.

Becton, Dickinson And Company Stock Insights

Price Movement
In the last 6 months, BDX stock has moved down by -14.5%
Increasing Revenue
Becton, Dickinson And Company has shown consistent growth in its revenue over the last three quarters. The revenue increased from $5.16 billion to $5.50 billion, resulting in an average rise of 3.1% per quarter.
Increasing Net Profit
Becton, Dickinson and Company has shown a positive trend in its net profit over the last three quarters. The profit increased from $303.0 million to $574.0 million, resulting in an average quarterly increase of 24.0%. This consistent growth indicates improving financial performance for the company.
BDX vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 12.2% return, outperforming this stock by 32.6%
BDX vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 25.2% return, outperforming this stock by 49.6%
Price to Sales
Becton, Dickinson and Company (BDX) has a price-to-sales ratio of 2.6, meaning investors are willing to pay $2.60 for every $1 of sales the company generates. In comparison, Resmed Inc. has a higher price-to-sales ratio of 7.8, indicating that investors pay more for every dollar of sales for Resmed than for BDX.

Becton, Dickinson And Company Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$17.3B	↑ 8.18%
Net Income	$1.2B	↑ 296.46%
Net Profit Margin	7.13%	↑ 5.18%

	FY20	Y/Y Change
Revenue	$16.1B	↓ 7.03%
Net Income	$874.0M	↓ 29.12%
Net Profit Margin	5.44%	↓ 1.69%

	FY21	Y/Y Change
Revenue	$19.1B	↑ 19.02%
Net Income	$2.1B	↑ 139.36%
Net Profit Margin	10.94%	↑ 5.5%

	FY22	Y/Y Change
Revenue	$18.9B	↓ 1.36%
Net Income	$1.8B	↓ 14.96%
Net Profit Margin	9.43%	↓ 1.51%

	FY23	Y/Y Change
Revenue	$19.4B	↑ 2.66%
Net Income	$1.5B	↓ 16.58%
Net Profit Margin	7.66%	↓ 1.77%

	FY24	Y/Y Change
Revenue	$20.2B	↑ 4.16%
Net Income	$1.7B	↑ 14.89%
Net Profit Margin	8.45%	↑ 0.79%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$5.0B	↑ 7.2%
Net Income	$537.0M	↑ 91.1%
Net Profit Margin	10.64%	↑ 4.67%

	Q2 FY24	Q/Q Change
Revenue	$5.0B	↓ 1.09%
Net Income	$487.0M	↓ 9.31%
Net Profit Margin	9.76%	↓ 0.88%

	Q3 FY24	Q/Q Change
Revenue	$5.4B	↑ 8.96%
Net Income	$421.0M	↓ 13.55%
Net Profit Margin	7.74%	↓ 2.02%

	Q4 FY24	Q/Q Change
Revenue	$5.2B	↓ 4.95%
Net Income	$303.0M	↓ 28.03%
Net Profit Margin	5.86%	↓ 1.88%

	Q1 FY25	Q/Q Change
Revenue	$5.3B	↑ 2.01%
Net Income	$308.0M	↑ 1.65%
Net Profit Margin	5.84%	↓ 0.02%

	Q2 FY25	Q/Q Change
Revenue	$5.5B	↑ 4.5%
Net Income	$574.0M	↑ 86.36%
Net Profit Margin	10.42%	↑ 4.58%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$8.3B	↑ 14.02%

	FY20	Y/Y Change
Profit	$6.8B	↓ 17.98%

	FY21	Y/Y Change
Profit	$8.6B	↑ 26.96%

	FY22	Y/Y Change
Profit	$8.5B	↓ 1.78%

	FY23	Y/Y Change
Profit	$8.2B	↓ 3.62%

	FY24	Y/Y Change
Profit	$9.1B	↑ 11.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$2.3B	↑ 13.67%

	Q2 FY24	Q/Q Change
Profit	$2.3B	↑ 0.13%

	Q3 FY24	Q/Q Change
Profit	$2.5B	↑ 9.02%

	Q4 FY24	Q/Q Change
Profit	$2.2B	↓ 11.13%

	Q1 FY25	Q/Q Change
Profit	$2.3B	↑ 0.98%

	Q2 FY25	Q/Q Change
Profit	$2.6B	↑ 16.7%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$3.3B	↑ 16.23%
Investing Cash Flow	$-741.0M	↓ 95.32%
Financing Cash Flow	$-3.2B	↑ 5556.14%

	FY20	Y/Y Change
Operating Cash Flow	$3.5B	↑ 6.28%
Investing Cash Flow	$-1.2B	↑ 66.26%
Financing Cash Flow	$22.0M	↓ 100.68%

	FY21	Y/Y Change
Operating Cash Flow	$4.6B	↑ 31.31%
Investing Cash Flow	$-1.9B	↑ 52.6%
Financing Cash Flow	$-3.3B	↓ 15127.27%

	FY22	Y/Y Change
Operating Cash Flow	$2.6B	↓ 43.34%
Investing Cash Flow	$-3.2B	↑ 71.28%
Financing Cash Flow	$-591.0M	↓ 82.12%

	FY23	Y/Y Change
Operating Cash Flow	$3.0B	↑ 13.52%
Investing Cash Flow	$-716.0M	↓ 77.76%
Financing Cash Flow	$-2.0B	↑ 231.13%

	FY24	Y/Y Change
Operating Cash Flow	$3.8B	↑ 27.07%
Investing Cash Flow	$-5.5B	↑ 670.11%
Financing Cash Flow	$2.1B	↓ 206.64%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$515.0M	↓ 38.76%
Investing Cash Flow	$-1.1B	↑ 353.22%
Financing Cash Flow	$1.7B	↓ 297.8%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.3B	↑ 145.44%
Investing Cash Flow	$-288.0M	↓ 72.73%
Financing Cash Flow	$1.1B	↓ 34.31%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$1.2B	↓ 6.8%
Investing Cash Flow	$-3.9B	↑ 1267.01%
Financing Cash Flow	$124.0M	↓ 88.93%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$693.0M	↓ 41.17%
Investing Cash Flow	$204.0M	↓ 105.18%
Financing Cash Flow	$-1.9B	↓ 1654.84%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$164.0M	↓ 76.33%
Investing Cash Flow	$-192.0M	↓ 194.12%
Financing Cash Flow	$-39.0M	↓ 97.98%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$1.2B	↑ 643.29%
Investing Cash Flow	$-336.0M	↑ 75.0%
Financing Cash Flow	$-841.0M	↑ 2056.41%

Becton, Dickinson And Company Technicals Summary

Sell

Neutral

Buy

Becton, Dickinson And Company is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Becton, Dickinson And Company Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Becton, Dickinson And Company	7.87%	-15.53%	-20.32%	-23.68%	-21.61%
Intuitive Surgical, Inc.	-2.08%	-16.52%	-2.1%	132.38%	85.58%
Alcon Ag	-9.12%	-15.22%	-16.6%	20.36%	37.6%
West Pharmaceutical Services Inc	3.59%	8.29%	-18.81%	-15.24%	-14.26%
Resmed Inc.	-5.81%	17.76%	12.09%	27.1%	50.01%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Becton, Dickinson And Company	35.34	35.34	0.97	14.37	0.06	0.04	0.02	88.87
Intuitive Surgical, Inc.	66.2	66.2	3.47	8.14	0.16	0.09	NA	49.79
Alcon Ag	36.95	36.95	2.16	3.1	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.91	36.91	3.57	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	28.9	28.9	1.85	9.5	0.26	0.14	0.01	40.77

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Becton, Dickinson And Company	Buy	$55.3B	-21.61%	35.34	7.41%
Intuitive Surgical, Inc.	Buy	$169.7B	85.58%	66.2	28.51%
Alcon Ag	Buy	$39.5B	37.6%	36.95	10.7%
West Pharmaceutical Services Inc	Buy	$17.8B	-14.26%	36.91	16.48%
Resmed Inc.	Buy	$40.2B	50.01%	28.9	27.22%

Becton, Dickinson And Company Dividend announcements

Becton, Dickinson And Company Dividends September, 2025
In the quarter ending September,2025. Becton, Dickinson And Company has declared dividend of $1.04

About Becton, Dickinson And Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Organization	Becton, Dickinson And Company
Employees	70000
CEO	Mr. Thomas E. Polen Jr.
Industry	Health Technology

Key Management of Becton, Dickinson And Company

Name	Title
Mr. Thomas E. Polen Jr.	President, CEO & Chairman
Mr. Christopher J. DelOrefice CPA	Executive VP & CFO
Ms. Shana Carol Neal	Executive VP & Chief People Officer
Mr. Michael Garrison	Executive VP & President of Medical segment
Mr. Richard Byrd	Executive VP & President of Interventional Segment
Ms. Pamela L. Spikner	Senior VP, Chief Accounting Officer & Controller
Ms. Elizabeth McCombs	Executive VP & Chief Technology Officer
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.	Senior VP & Chief Scientific Officer
Ms. Denise Russell Fleming	Executive VP of Technology & Global Services and Chief Information Officer
Mr. Greg Rodetis	Senior VP, Treasurer & Head of Investor Relations

Important FAQs about investing in BDX Stock from India :

What is Becton, Dickinson And Company share price today?

Becton, Dickinson And Company share price today is $192.88 as on August 30, 2025 at 1:29 am IST at the close of the market. Becton, Dickinson And Company share today touched a day high of $192.97 and a low of $191.66.

What is the 52 week high and 52 week low for Becton, Dickinson And Company share?

Becton, Dickinson And Company share touched a 52 week high of $251.99 and a 52 week low of $163.33. Becton, Dickinson And Company stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $192.88, lower by 23.46% versus the 52 week high.

How to invest in Becton, Dickinson And Company Stock (BDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Becton, Dickinson And Company on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Becton, Dickinson And Company Shares that will get you 0.0078 shares as per Becton, Dickinson And Company share price of $192.88 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Becton, Dickinson And Company Stock (BDX) from India?

Indian investors can start investing in Becton, Dickinson And Company (BDX) shares with as little as ₹88.286 or $1 (as of September 01, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Becton, Dickinson And Company stock (as per the Rupee-Dollar exchange rate as on September 01, 2025). Based on Becton, Dickinson And Company share’s latest price of $192.88 as on August 30, 2025 at 1:29 am IST, you will get 0.0518 shares of Becton, Dickinson And Company. Learn more about fractional shares .

What are the returns that Becton, Dickinson And Company has given to Indian investors in the last 5 years?

Becton, Dickinson And Company stock has given -21.61% share price returns and 20.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?